Recalls / Generics / Papaverine Hydrochloride
Papaverine Hydrochloride
1 FDA drug recall involving generic “Papaverine Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-03-14 | Class II | PAPAVERINE HYDROCHLORIDE Injection, USP, 60 mg/2mL (30 mg/mL), packaged as a) 25 x 2mL Single Use Vials per bo | Vitae Enim Vitae Scientific, Inc. |